Data Analytics

Syntellis Performance Solutions to Acquire Stratasan

The combined power of Syntellis and Stratasan technologies will accelerate data-driven, comprehensive decision-making for healthcare organizations across the country

Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced a definitive agreement to acquire Stratasan, an industry leader in advanced healthcare market intelligence and data analytics

Through this acquisition, Syntellis will expand its suite of intelligent planning and performance solutions by adding Stratasan’s powerful strategic growth capabilities. This combination will deliver unparalleled intelligence and insights to healthcare leaders and create the industry’s most robust set of tools designed to help providers and other healthcare organizations strategically determine where, when and how to grow.

“Now more than ever, healthcare organizations need data and intelligence solutions that help them grow profitably and improve outcomes in the face of extraordinary changes and challenges,” said Flint Brenton, CEO of Syntellis. “With the powerful combination of Syntellis’ leading software, data and intelligence solutions and Stratasan’s advanced analytics and market intelligence, we’ll connect operational, financial and strategic data to empower healthcare leaders to improve their performance, deliver exceptional outcomes and maximize their impact in the communities they serve.”

Stratasan is a nationally recognized provider of data analytics software and services for hospitals, ancillary care centers, healthcare consultants, and payers, helping them improve the efficiency and effectiveness of strategic growth efforts by delivering advanced market intelligence and data analytics.

“For more than a decade, leading national healthcare organizations have relied on our software and services to provide a clear picture of what’s going on in their target markets — so they know where to grow,” said Jason Moore, CEO of Stratasan. “We look forward to furthering our mission as part of Syntellis and continuing to help hospitals and healthcare entities across the country better serve their markets and maximize strategic impact.”

Thoma Bravo and Madison Dearborn Partners are Syntellis’ primary investors.

Ernst & Young Global Limited acted as financial advisor and Kirkland & Ellis LLP served as legal advisor to Syntellis. Canaccord Genuity, LLC acted as financial advisor and McDermott Will & Emery LLP served as legal advisor to Stratasan.

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

Arcadia receives recognition from three major organizations

PR Newswire

Annalect and InfoSum Launch New Data Collaboration Capabilities

Business Wire

Docebo Adds Learning Analytics to Multi-product Suite

Business Wire